Eligibility for Listing – Premium Listing
Scientific Research Based Company
For issuers to be admitted on or after 16 May 2014
Name of Company:
Nature of Transaction:
New applicant
Name of Sponsor
Date Submitted:
Rule
Page
Proof Comment (where applicable)
Number
LR 2
Required by LR6.1.2
Duly incorporated
2.2.1 (1)
2.2.1 (2)
Operating in conformity with
constitution
2.2.2 (1)
Conforms with law of place of
constitution
2.2.2 (2)
Duly authorised
2.2.2 (3)
Statutory and other consents
2.2.3
Admitted on RIE
2.2.4 (1)
Freely transferable
2.2.4 (2)
Fully paid
2.2.7 (1)
Minimum market capitalisation
2.2.9 (1)
Whole class to be listed
2.2.10 (2)(a)
Prospectus approved by FCA and
published
2.2.10 (2)(b)
Other EEA home member state
documentation
LR 6
6.1.3 (1)(b)
6/9 month rule
6.1.3 (1)(c)
Accounts consolidated
6.1.3 (1)(d)
Reported on in accordance with
standards acceptable under item
20.1 of Annex I of the PD
regulation
6.1.3 (1)(e)
Not subject to a modified report,
except as set out in LR 6.1.3AG or
LR 5.6.21R
6.1.3 (2)(a)
Independent person providing the
opinion
6.1.3 (2)(b)
Confirmation from person
providing the opinion
1 of 3
May 2014
Rule
Page
6.1.3D (1)
Where insufficient to meet 75%
requirement: historical financial
information related to acquired
entities for 3 years prior to
acquisition
6.1.3D (2)
Consistent with accounting policies
adopted
Not subject to a modified report
6.1.3D (3)
6.1.3D (4)
In aggregate, represents 75% of
enlarged business
6.1.4
Independent business as main
activity
6.1.4B(1)
Written agreement with controlling
shareholder
6.1.4B(2)
Constitution that allows for election
in accordance with LR 9.2.2ER
and LR 9.2.2FR
Agreement with appropriate
number of controlling shareholders
in light of understanding
Agreement includes procurement
provision
6.1.4C(1)
6.1.4C(2)(a)
6.1.4C(2)(b)
Agreement includes names of nonsigning controlling shareholders
6.1.4D(1)
Agreement includes undertaking
regarding transactions
6.1.4D(2)
Agreement includes undertaking
regarding compliance with
obligations
Agreement includes undertaking
regarding resolutions
6.1.4D(3)
6.1.11 (1)
6.1.12 (1)
Published or filed historical
financial information since
inception
Demonstrate ability to attract funds
from sophisticated investors prior
to marketing at time of listing
6.1.12 (2)
Raising at least £10m
6.1.12 (3)
Market cap before fundraising of
£20m
6.1.12 (4)
Use finance to bring identified
product to revenue generating
stage
6.1.12 (5)
Demonstrate that it has 3 yr record
of operations in laboratory
research and development
including:
(a) details of patents
granted or details of
progress of patent
applications; and
(b) successful completion
of, or the successful
progression of,
significant testing of the
effectiveness of its
products
Working capital
6.1.16
6.1.19 (1)
Proof Comment (where applicable)
Number
Shares in public hands in EEA
states
2 of 3
May 2014
Rule
Page
6.1.22 (1)
Warrants limited to 20%
6.1.23
Compatible with electronic
settlement
Constitution provides at least
equivalent rights
Conferring such rights not
incompatible with law of country of
incorporation
Discretion of board not limited or
transferred, and capable board
6.1.25 (1)
6.1.25 (2)
6.1.26
Proof Comment (where applicable)
Number
Constitution allows compliance
with LR 9.2.22R
6.1.28
Non-applicability Confirmation
We inform you that items marked “N/A” in the Page column of the above checklist are
considered not applicable and no equivalent information is available in relation to the
enclosed document.
Signed by:
On behalf of1:
1
The signatory should be properly authorised to do so on behalf of the sponsor
3 of 3
May 2014